China Health Technology Group Holding Company Limited
CHBOD
$0.05
$0.050.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.16M | 2.17M | 1.97M | 1.99M | 1.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.16M | 2.17M | 1.97M | 1.99M | 1.32M |
| Cost of Revenue | 1.97M | 1.98M | 2.10M | 2.12M | 1.06M |
| Gross Profit | 193.00K | 194.00K | -128.50K | -129.60K | 260.20K |
| SG&A Expenses | 663.10K | 666.30K | 956.70K | 965.00K | 625.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.63M | 2.65M | 3.06M | 3.09M | 1.68M |
| Operating Income | -470.10K | -472.40K | -1.09M | -1.09M | -365.60K |
| Income Before Tax | 350.50K | 352.20K | -96.90K | -97.70K | 13.95M |
| Income Tax Expenses | 4.40K | 4.50K | 300.00 | 300.00 | 100.00 |
| Earnings from Continuing Operations | 346.00K | 347.70K | -97.20K | -98.10K | 13.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 346.00K | 347.70K | -97.20K | -98.10K | 13.95M |
| EBIT | -470.10K | -472.40K | -1.09M | -1.09M | -365.60K |
| EBITDA | -462.20K | -464.50K | -1.07M | -1.08M | -361.10K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 79.24M | 79.24M | 71.55M | 71.55M | 62.73M |
| Average Diluted Shares Outstanding | 79.24M | 79.24M | 71.55M | 71.55M | 62.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |